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Background: Early discharge for patients with acute exacerbations of chronic obstructive
pulmonary disease (AECOPD) has been shown to be effective by clinical trials. To evaluate
its implementation and efficacy in clinical practice, data concerning early discharge
schemes (EDS) from the 2003 National COPD Audit were collected and analysed.
Methods: All acute Trusts in the UK were surveyed in Autumn 2003 by two means: one a
questionnaire relating to organisation of care and second an audit of 40 clinical cases
admitted with AECOPD.
Results: Data were available for both organisation of care and clinical activity for 233
units, of which 103 (44%) had EDS. Models of care included admission prevention in the
accident and emergency department (5%), rapid discharge in o48 h (27%), assisted
discharge occurring 2 days or more after admission (24%) and combinations of these (12%).
There was wide variation in organisation of care overall. 30% of patients in units with EDS
were discharged early from hospital. Units with EDS had an average LOS 1-day shorter with
no increase in readmission rate (32% vs. 32%) as for those without an EDS and no increase in
mortality.
Conclusions: There is wide variation in the availability of EDS for AECOPD in the UK, with
increasing implementation of schemes. Thirty percent of patients can effectively be put
into EDS which is higher than the figure of 25% from randomised controlled trials (RCTs).
Mortality and readmission rates are the same as for units where no EDS is available and
similar to results reported in RCTs. EDS therefore appears to be effective in routine clinical
practice.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
1 964 929 or +44 2085 356 642; fax: +44 2085 356 709.
hippsx.nhs.uk (S.J. Quantrill).
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Figure 1 Number of hours per day EDS runs.
Early discharge schemes for COPD 1027Introduction
Studies of early discharge schemes (EDS) for acute exacer-
bations of chronic obstructive pulmonary disease (AECOPD)
have shown that about 25% of such patients may be safely
and effectively cared for in the home environment1 and the
UK National Institute for Health and Clinical Excellence
(NICE) Guidelines state that where possible they should be
managed at home.2 Seven randomised controlled trials have
confirmed the efficacy of EDS for AECOPD, if certain criteria
are met.3–9 This research, combined with increasing
pressure on hospital trusts to create bed space, has led to
the introduction of EDS in the UK. Early discharge results in
significant reductions to hospital bed days and economic
benefits.10
A previous survey of British practice in 199911 revealed
that 30 (16% surveyed) respiratory departments had set up
EDS with a wide variation in organisation of services. A high
level of interest was noted, with lack of funding stated as
the main barrier to setting up EDS. Various models of early
discharge exist, but it is unknown, which have been adopted
by different hospitals, if the favourable outcomes of the
research trials translate to daily clinical practice and how
effective they are when implemented on a large scale. This
study aimed to explore data relating to early discharge from
the 2003 UK National COPD Audit12 which was not included
in the previous UK COPD Audit,13 thus enabling us to provide
an overview of the organisation of EDS and their efficacy.
Information presented here relating to the number and
make-up of schemes operating in the UK could be useful to
healthcare planners and individual trusts intending to set up
EDS.
Methods
The 2003 National COPD Audit aimed to survey all acute
trusts in the UK, to update and expand on data gathered
from the 2001 UK COPD Audit.13 Detailed methodology
relating to the audit has been described elsewhere.12 All
hospital units in the UK responsible for the care of patients
with AECOPD were asked to record clinical activity data on
40 consecutive admissions between 1st September and 14th
November 2003, including information relating to severity of
exacerbation at presentation, readmission and mortality
rates. In a separate resources and organisation question-
naire hospital units were also asked questions such as how
many staff are employed in their unit, whether or not there
is an admissions ward, pulmonary rehabilitation, etc. This
questionnaire also asked for information regarding EDS such
as whether or not the unit has a scheme, how many hours a
week it is run and by which staff.
Statistical analysis
Fishers Exact test (2 comparison groups) or the w2 test (42
groups) was used to test the association between organisa-
tional aspects of units including geographical location and
whether or not they ran EDS. Spearman’s coefficient was
used to measure correlation of the number of COPD patients
admitted to units in 2002 with numbers of respiratory nurses
and physiotherapists involved in EDS. Presentation of clinicalactivity was largely descriptive. The P values for assessing
the significance of the readmission rate variation by total
time in care (as a continuous variable) was obtained using
Stata8 ‘binreg’ software (StataCorp, College Station, Texas)
adjusting for site clustering. The net effect of EDS on length
of stay (LOS) was estimated using random effects regression
analyses (Stata8 ‘xtreg’) that adjusted for patient cluster-
ing. LOS values were log transformed to satisfy normality
assumptions with 0.5 added to zero values (2% of patients)
before transformation. Results were converted back to the
original scale for presentation as a geometric mean with 95%
confidence interval.
Results
Organisation of schemes
Of 193 Trusts eligible to take part 187 registered, comprising
247 hospital units. Organisational and clinical data were
provided by 233 units and in 130 (56%) of these COPD
patients had no access to EDS. A total of 103 (44%) units with
access to EDS employed various models of early discharge
including admission prevention (early discharge from emer-
gency department) in 5 (5%), rapid discharge o48 h in 26
(27%), assisted discharge 448 h in 23 (24%) and ‘other’ for
47 (46%). Combinations of the three models were stated in
12 (12%) of the ‘other’ models but no details of the ‘other’
models were given for 35.
The numbers of patients accepted for early discharge in
the preceding 12 months was self-reported by 82 units, with
a median 110 and inter-quartile range 61–217 patients.
Most schemes operated on a Monday–Friday basis (64% of
units with schemes) but some (27%) provided a 7-day scheme
and one provided a 4-day scheme, whilst for 8 this was
stated as unknown. Two-thirds of units ran schemes for 7–8 h
during the daytime, but there was wide variation (Fig. 1).
Respiratory nurses ran 83 (81%) schemes, general nurses
11 (11%), physiotherapists 2 (2%) and both physiotherapists
and nurses in 2 (2%). General practitioners had input into 7%
(5/75) of schemes (data unknown for 28), respiratory
consultants into 88% (85/97), respiratory nurses into 88%
(84/95), physiotherapists into 48% (43/89) and district
nurses, health visitors or community nurses in 21% (17/82)
of schemes. The variation in numbers of respiratory nurses
and physiotherapists involved in schemes are shown in
Figs. 2 and 3.
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Figure 2 Respiratory nurse input.
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Figure 3 Physiotherapy input.
Table 1 Organisation of units and EDS.
Total % (n/N) of units with EDS P value
% n/N
44 103/233
Country
England 50 90/181 0.001
N Ireland 8 1/13
Scotland 48 10/21
Wales 11 2/18
Hospital bed no’sy (tertiles)
128–464K 26 20/77 o0.001
465–702K 43 34/79
707–1903K 64 49/77
COPD patients in 2002 (tertiles)
o364 32 24/76 0.02
364–638 48 36/75
4638 54 40/74
Admissions ward
No 26 7/27 0.06
Yes 47 96/206
Daily post-take consultant ward rounds
One 39 36/93 0.22
Two 47 63/134
Specialist respiratory ward
No 26 21/80 o0.001
Yes 54 82/153
High dependency unit
No 37 16/43 0.40
Yes 46 87/190
Specialty triage
No 39 61/155 0.04
Yes 54 42/78
Pulmonary rehabilitation
No 25 21/83 o0.001
Yes 55 82/150
S.J. Quantrill et al.1028There was little correlation between the number of COPD
patients admitted to units in 2002 and number of respiratory
nurses (Spearman correlation 0.06, P ¼ 0:57) or number of
physiotherapists (Spearman 0.02, P ¼ 0:86). Units in England
and Scotland were significantly more likely to have EDS than
units in Wales or Northern Ireland (Table 1).
Early discharge schemes were significantly more common
in hospitals that had greater numbers of beds, higher
numbers of COPD admissions, a specialist respiratory ward,
specialty triage, a pulmonary rehabilitation service, and
respiratory nurse.Ward-based system
No 37 35/94 0.08
Yes 49 68/138
Access to respiratory nurse
No 30 19/64 0.008
Yes 50 84/169
Fishers exact test (2 comparison groups) or w2-test (42
groups).
yBinley’s Directory of NHS Management Spring 2004
Edition, published January 2004.Clinical activity
The 233 units collected data on 7529 patients in 8013
episodes of care. Only the first episode for each case was
analysed. Overall 14% (1046) of patients were accepted for
early discharge and home care which represented 30%
(1046/3511) of patients from those 103 units offering
schemes. There were no differences in any of the presenting
patient characteristics between hospitals offering and not
offering an EDS (data not shown). Within the 103 units
offering EDS, the clinico-demographic characteristics of
those patients in EDS were similar to those of patients not in
EDS (Table 2).
Although median admission pH was similar in the two
groups, patients accepted into EDS tended to have a higher
pH: pH o7.26 in 6% (56/904) EDS vs. 9% (172/2007) not in
EDS, pH 7.26–7.34 in 12% (112/904) EDS vs. 16% (312/2007)not in EDS, and pHX7.35 in 81% EDS vs. 76% (1523/2007) not
in EDS. Non-invasive ventilation was administered during
hospital admission to 5% (54/1011) of patients selected for
EDS.
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Table 2 Characteristics of patients in EDS and not in EDS, in those units offering EDS.
EDS (1046) Not in EDS (2465)
Age Median (IQR), n 72 (65–78) 1046 72 (64–78) 2459
Gender male %, n 52% 547 52% 1286
Previous admission %, n 72% 729/1013 67% 1564/2343
Lives alone %, n 39% 377/995 39% 909/2322
Current smokers %, n 40% 406/1017 41% 966/2346
PS: normal/ strenuous %, n 31% 292/952 31% 682/2224
PS: limited but selfcare %, n 48% 458/952 44% 986/2224
PS: limited selfcare/ bed/chair bound %, n 21% 202/952 25% 556/2224
% predicted FEV1 Median (IQR), n 37 (27–50) 630 38 (28–50) 1084
pH on admission Median (IQR), n 7.41 (7.36–7.44) 904 7.40 (7.35–7.44) 2007
PO2 on admission Median (IQR), n 9.26 (7.80–11.73) 905 9.10 (7.54–11.70) 2011
PS, performance status.
Table 3 Length of stay, readmission and mortality in relation to EDS.
Sites with access to EDS Sites with no access to EDS
EDS (1046) Not in EDS (2465) (4018)
LOS in hospital Median (IQR), n 4 (2–7) 998 7 (4–11) 2055 7 (4–11) 3491
Total LOS in EDS Median (IQR), n 11 (7–16) 633
Readmission rate %, n 32% 319/990 32% 681/2102 31% 1069/3494
Mortality at 90 days %, n 7% 66/1011 19% 442/2381 16% 604/3882
LOS, length of stay, excluding inpatient deaths.
Early discharge schemes for COPD 1029Clinical outcomes
Readmission rates for discharged patients were similar for
units that ran early discharge schemes or did not, at 31%
(1069/3494) with no scheme and 32% (1000/3092) with a
scheme. In the 103 units with a scheme, readmission rates
after discharge were 32% (319/990) for patients accepted
into the scheme and 32% (681/2102) for patients not
accepted (Table 3).
Rates were also similar after stratification for previous
admission (to this index admission) and poor performance
status, factors that other analyses of the audit data12 have
shown to be the two main predictors of readmission (results
not given).
For the 103 units running EDS LOS varied as shown in
Table 3. Mean LOS was 5.57 days for those in EDS (n ¼ 998),
9.40 days for those not in EDS in sites with access
(n ¼ 2055), and 9.17 days for those in sites with no access
(n ¼ 3491). The mean LOS in those sites with EDS was 8.15
days as compared to 9.17 days for sites without access, so
the net effect of running EDS in a site is 1 day in hospital
saved, averaged per COPD admission. Random effects
regression confirmed this reduction, geometric mean 0.82
days saved (95% CI 0.76–0.89, Po0:001) after adjustment
for whether units had specialist respiratory wards, pulmon-
ary rehabilitation, and patient clustering.
The readmission rate was slightly lower at 30% (58/194)
for those staying longest in total care (414 days), as
compared to 33% (72/221) for those staying 9–14 days and
36% (76/209) for stays under 9 days (P ¼ 0:17), thesecategories representing the tertile split for patients with
known total length of care.
Mortality rates at 90 days following discharge from
hospital (Table 4) were consistently lower amongst patients
who were discharged via EDS despite very similar clinical
characteristics (Table 2). In regression analyses involving all
7529 patients the most important independent predictors of
90 day mortality were performance status, blood urea,
serum albumin, arterial pH, arterial oxygen saturation and
age.12 These predictors of outcome show similar relation-
ships for the EDS patients but at lower levels (Table 4).
Random effects logistic regression adjusting for patient
clustering gave very similar odds ratio estimates of the risk
ratios for EDS patients (results not shown).Discussion
This audit shows that implementation of EDS has varied
considerably and is subject to significant geographical varia-
tion. Most units still had no access to EDS in 2003 and practice
continues to vary widely with regards to the model adopted
and staffing available. Given the choice both patients and their
carers would prefer to be treated at home rather than in
hospital5,14,15 and recent guidelines stress the importance of
patient preference,2 but EDS is only available in certain parts
of the country: a form of ‘‘postcode prescribing’’. The time
that schemes run for varies considerably in terms of numbers
of hours per day and days per week. The ideal model for home
care of AECOPD is unknown, but the numbers of healthcare
ARTICLE IN PRESS
Table 4 Predictors of 90 day mortality on admission for patients in EDS.
Sites with EDS Sites with no EDS
Patients in EDS (1046) Patients not in EDS (2465) (4018)
% Died N RR % Died RR % Died RR
Age
o65 3.0 7/233 10.1 7.6
65–74 6.3 24/378 2.11 17.6 1.75 12.7 1.66
75–84 8.9 31/350 2.95 22.4 2.23 21.5 2.81
85+ 8.0 4/50 2.66 35.5 3.52 26.8 3.51
Performance status
0. Normal 3.2 3/95 5.5 7.2
1. Strenuous 6.4 12/188 2.02 9.2 1.66 6.6 0.90
2. Limited activity 6.1 27/441 1.94 16.2 2.93 14.1 1.94
3. Limited selfcare 10.3 18/175 3.26 32.8 5.92 27.6 3.81
4. Bed/chair bound 13.6 3/22 4.32 48.1 8.70 47.5 6.56
Serum albumin (g/L)
34+ 6.2 34/551 16.2 12.7
o34 13.6 11/81 2.20 34.9 2.16 29.2 2.31
Blood urea (umol/L)
p7.1 3.9 25/635 12.9 10.9
47.1 12.8 36/281 3.25 27.0 2.09 23.9 2.18
pH
7.35+ 5.5 39/714 16.6 12.6
7.26–7.34 8.4 9/107 1.54 22.4 1.35 21.9 1.73
o7.26 13.0 7/54 2.37 37.3 2.24 41.0 3.25
O2 saturation
492% 5.4 27/504 17.6 14.1
86–92% 8.0 12/150 1.49 24.3 1.38 25.0 1.78
o86% 13.0 3/23 2.43 41.8 2.37 37.8 2.69
RR, Risk ratio.
S.J. Quantrill et al.1030professionals (mainly nurses) involved in EDS appear to be
small with a mode of 2 respiratory nurses per scheme. With
such numbers it is unsurprising that schemes do not run over
24h, but suggests there may be potential for more than 30% of
patients to have access to EDS. This study had insufficient
power to differentiate between models but the results do
support the conclusions of the RCT evidence that there are
overall benefits in terms of reduced hospital stays without
adverse effect.
The benefits of earlier discharge are reflected in terms of
less time in hospital (liked by patients)5,14 and appear to apply
to a larger percentage of patients in those units offering EDS
than the figure of 25% quoted in the metanalysis.1
Although median LOS in hospital was 3 days shorter for
patients enrolled into EDS, it was 4 days longer in terms of
time spent overall in the scheme (data not shown in results).
A prolonged overall care period within an EDS has been
noted before,3 but overall the gain from less inpatient daysis still cost effective.4 In hospitals with EDS the reduction of
just over a day for all AECOPD patients is a substantial
contribution to the acute admission problems. For the
average hospital with 451 admissions per year2 and a cost
per hospital day of £273 (Boehringer Ingelheim, personal
communication) this equates to just over £120,000 per
hospital which should more than cover the median of 2
nurses employed per hospital (Fig. 2). These savings of bed
days could potentially be amplified if more Trusts operated
EDS earlier during the admission, outside of normal daytime
working hours and at weekends. It is also a constructive shift
of funding toward primary care (conforming with current UK
government priorities).
Of the potential adverse effects, readmission rates within
90 days were high, similar to previous studies,3,4,8,9 and
higher for those with a previous admission or worse
performance status, but readmission rates were not higher
for patients treated within an EDS. The case-mix of patients
ARTICLE IN PRESS
Early discharge schemes for COPD 1031in EDS was similar to those not. Even patients presenting
with severe respiratory acidosis and requiring NIV, (typically
excluded from RCT trials), were accepted on to EDS: 6%
patients accepted on to EDS were severely acidotic (pH
o7.26) at presentation and 5% underwent treatment with
NIV. This may come as a surprise, but probably reflects the
fact that some very sick patients improve rapidly to a state
where early discharge is still possible. These results are
significant as they show that early discharge need not be
limited to patients with less severe exacerbations, as
previously thought, but that speed of initial recovery is also
important in determining suitability for early discharge.
Despite the similar case mix of patients, mortality rates
at 90 days were lower for the patients discharged via EDS.
This is presumably because less sick patients are accepted
into these schemes, and suggests there are other clinical
factors that clinicians use to assess suitability for early
discharge that we have not measured—a challenge for
future projects.
The limitations of this study relate to its observational
nature and that there will always be some incomplete data
(‘‘do not knows’’ and ‘‘not recorded’’) and an inability to
explore issues in greater depth than the questions originally
posed. However the data are strengthened by large numbers
(7529 patients compared with a total of only 754 from all
RCTs combined), the prospective identification of consecu-
tive admissions to each unit, and the completeness of the UK
coverage.
In summary, this large National Audit has confirmed that
early discharge is being used for 30% of patients admitted to
hospital with AECOPD in just under half of UK hospitals. Our
data support the RCTs in that LOS in hospital is significantly
reduced, without measurable adverse effect. These results
strengthen the recommendation in the NICE guideline2 that
EDS should be available across the UK.References
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